Project Grant HT94252510209
Award Date
5/1/25
Completion Date
4/30/27
Dollars Obligated
$488K
Federal Agency
Defense Health Agency
Awardee
The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. (UYLKBRENAPG5)
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Westlake, MD 20817, USA
Similar Awards
The Department of Defense's Defense Health Agency awarded a $313,151 Project Grant to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on February 15, 2024, supports a 2-year research project titled "AUGMENTING RET KINASE SIGNALING IN INTRINSIC NEURONAL REPAIR RESPONSES TO TREAT TRAUMATIC BRAIN INJURY". HJF, a global non-profit organization focused on...
The Department of the Army Medical Command awarded a $2,402,721 project grant under the Military Medical Research and Development (CFDA 12.420) program to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. The grant, awarded on April 15, 2025, with a completion date of April 14, 2027, will support the development of a patient monitoring and decision-support platform for precision health. The Henry M. Jackson Foundation, a global nonprofit organization, will leverage...
The U.S. Defense Health Agency awarded a $1,898,000 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) to develop a rapid, fieldable nanopore sequencing-based prognostic and diagnostic assay to advance clinical management decision-making. The 3-year grant, starting on September 30, 2024, will fund research to create innovative medical technologies that can improve health...
The Department of the Army Medical Command awarded a $1,622,955 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) on September 15, 2024. The grant, titled "LACRIPEP: A NOVEL THERAPEUTIC AGENT FOR CORNEAL WOUND HEALING AND OCULAR SURFACE HOMEOSTASIS," supports advanced biomedical research focused on developing innovative treatments for military personnel and...
The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. was awarded a $2,727,382 cooperative agreement from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The cooperative agreement will support research into blood-based biomarkers of traumatic brain injury and related vascular dementia from September 1, 2022 to August 31, 2026. Through this funding, the Foundation will investigate...
This $1,460,695 Project Grant award was made by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant was awarded to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) on September 1, 2025, with a final completion date of August 31, 2028. The purpose of this grant is to support the DEVELOPMENT AND VALIDATION OF AN EPIGENOMIC LANDSCAPE AND NOVEL IMMUNOTHERAPY IN PROSTATE CANCER...
The Defense Health Agency awarded a $1,329,963 Cooperative Agreement to The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. (HJF) under the Military Medical Research and Development program (CFDA 12.420). The agreement supports a four-year study on transtibial osseointegration surgery, with a project period from September 30, 2023 to September 29, 2027. HJF, a nonprofit organization focused on accelerating progress in military medicine, has extensive experience...
The Defense Health Agency awarded a $1,030,660 Project Grant to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, awarded on September 30, 2024, will support research to study the link between successful osseointegration and sensorimotor control, with the ultimate completion date set for September 29, 2028. The Henry M. Jackson Foundation, an established federal...
The Department of the Army Medical Command, through the Military Medical Research and Development (CFDA 12.420) federal grant program, awarded Encephalogix, Inc. a $459,994 Project Grant to support epilepsy research. The award, effective from Sep 1, 2024 to Aug 31, 2025, will fund the company's "Epilepsy Research Program Idea Development Award" to explore innovative approaches to the prevention, diagnosis, treatment, and management of epilepsy, a condition relevant to military...
The Defense Health Agency awarded a $478,061 Project Grant to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. under the Military Medical Research and Development program (CFDA 12.420). This grant, with a performance period from September 1, 2024 to August 31, 2026, supports the development of an organoid model for ovarian cancer research and precision medicine. The Henry M. Jackson Foundation, a global non-profit organization, will use this funding to advance...